Delivery Order SPE2DX22D0129-SPE2D826F0DLD
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,127.28 on January 29, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and utilizes no set-aside designation, indicating it was competitively awarded. This delivery order represents a task order issued under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $128,180.25 on January 15, 2026, by the Defense Logistics Agency Medical Supply Chain. The contract utilizes firm fixed-price pricing with an ultimate completion date of January 16, 2026, and was competitively awarded without any set-aside designation. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $40,566.20 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which concludes on January 14, 2026, represents a competitively awarded contract with no set-aside designation. The award leverages Amerisourcebergen's established relationship with the federal government as a critical...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,807 by the Defense Logistics Agency's Medical Supply Chain on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a child order under Amerisourcebergen's significant Indefinite Delivery Contract with DLA Troop Support...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,375.58 on January 12, 2026, with a completion date of January 13, 2026. This firm fixed-price contract, issued by the Defense Logistics Agency's Medical Supply Chain, represents a non-set-aside competitive award. The delivery order is a child contract under Amerisourcebergen's parent organization, Cencora, Inc., which holds a substantial...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $110,752.60 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 15, 2026, was competitively awarded with no set-aside designation. The award is issued as a child contract under the parent organization Cencora, Inc. (doing business as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $107,779.05 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside award represents a child contract under Cencora, Inc. (the parent entity operating as Amerisourcebergen), and is issued under the company's existing Indefinite Delivery Contract with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,386.72 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under the parent entity...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,018.18 on February 2, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract carries a firm fixed-price structure with an ultimate completion date of February 3, 2026, and represents a non-set-aside competitive award. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DLDDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $11,659.64 by the Defense Logistics Agency Medical Supply Chain on February 2, 2026. This firm fixed-price, non-set-aside contract has an ultimate completion date of February 3, 2026 and represents a child contract under the parent entity Cencora, Inc. (doing business as Amerisourcebergen). The delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The Indefinite Delivery Contract enables Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet government procurement requirements through open competition, serving critical customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order exemplifies the company's role as a primary vendor for essential pharmaceutical commodities supporting military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 2/1/26 |